Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
  1. 4/A Planned sale VP Finance & Operations sold 440 shares at an average $0.37 ($161)
  2. 4/A Planned sale President and CEO sold 5,225 shares at an average $0.36 ($1,906)
  3. 4/A Planned sale Chief Scientific Officer sold 2,610 shares at an average $0.36 ($953)
  4. 4/A Planned sale VP Finance & Operations sold 224 shares at $0.35 ($78)
  5. 4/A Planned sale President and CEO sold 2,773 shares at $0.34 ($943)
  6. 4/A Planned sale Chief Scientific Officer sold 1,384 shares at $0.34 ($471)
  7. 4 Planned sale Chief Scientific Officer sold 2,610 shares at an average $0.36 ($953)
  8. 4 Planned sale VP Finance & Operations sold 440 shares at an average $0.37 ($161)
  9. 4 Planned sale President and CEO sold 5,225 shares at an average $0.36 ($1,906)
  10. 4 Planned sale VP Finance & Operations sold 224 shares at $0.35 ($78)
  11. 4 Open-market sale President and CEO sold 2,773 shares at $0.34 ($943)
  12. 4 Planned sale Chief Scientific Officer sold 1,384 shares at $0.34 ($471)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 18 · 354 filings